Yat-Fung Shea1,2, Warren Barker1, Maria T Greig-Gusto1, David A Loewenstein3, Ranjan Duara1,4, Steven T DeKosky5. 1. Wien Center for Alzheimer's Disease and Memory Disorder, Mount Sinai Medical Center, Miami Beach, FL, USA. 2. Department of Medicine, LKS Faculty of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong. 3. Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, FL, USA. 4. Departments of Neurology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL and University of Florida College of Medicine, Gainesville, FL, USA. 5. Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
Abstract
BACKGROUND: Patients with cognitive impairment or dementias of uncertain etiology are frequently referred to a memory disorders specialty clinic. The impact of and role for amyloid PET imaging (Aβ-PET) may be most appropriate in this clinical setting. OBJECTIVE: The primary objective of this study was to perform a systematic review and meta-analysis of the impact of Aβ-PET on etiological diagnosis and clinical management in the memory clinic setting. METHODS: A search of the literature on the impact of Aβ-PET in the memory clinic setting between 1 January 2004 and 12 February 2018 was conducted. Meta-analysis using a random effects model was performed to determine the pooled estimate of the impact of Aβ-PET in the changes of diagnoses and changes in management plan. RESULTS: After rigorous review, results from 13 studies were extracted, involving 1,489 patients. Meta-analysis revealed a pooled effect of change in diagnoses of 35.2% (95% CI 24.6-47.5). Sub-analyses showed that the pooled effect in change in diagnoses if Aβ-PET was used under the appropriate use criteria (AUC) or non-AUC criteria were 47.8% (95% CI 25.9-70.5) and 29.6% (95% CI: 21.5-39.3), respectively. The pooled effect of a change of diagnosis from Alzheimer's disease (AD) to non-AD and from non-AD to AD were 22.7% (95% CI: 17.1-29.5) and 25.6% (95% CI: 17.6-35.8), respectively. The pooled effect leading to a change of management was 59.6% (95% CI 39.4-77.0). CONCLUSIONS: Aβ-PET has a highly significant impact on both changes in diagnosis and management among patients being seen at a specialty memory clinic.
BACKGROUND:Patients with cognitive impairment or dementias of uncertain etiology are frequently referred to a memory disorders specialty clinic. The impact of and role for amyloid PET imaging (Aβ-PET) may be most appropriate in this clinical setting. OBJECTIVE: The primary objective of this study was to perform a systematic review and meta-analysis of the impact of Aβ-PET on etiological diagnosis and clinical management in the memory clinic setting. METHODS: A search of the literature on the impact of Aβ-PET in the memory clinic setting between 1 January 2004 and 12 February 2018 was conducted. Meta-analysis using a random effects model was performed to determine the pooled estimate of the impact of Aβ-PET in the changes of diagnoses and changes in management plan. RESULTS: After rigorous review, results from 13 studies were extracted, involving 1,489 patients. Meta-analysis revealed a pooled effect of change in diagnoses of 35.2% (95% CI 24.6-47.5). Sub-analyses showed that the pooled effect in change in diagnoses if Aβ-PET was used under the appropriate use criteria (AUC) or non-AUC criteria were 47.8% (95% CI 25.9-70.5) and 29.6% (95% CI: 21.5-39.3), respectively. The pooled effect of a change of diagnosis from Alzheimer's disease (AD) to non-AD and from non-AD to AD were 22.7% (95% CI: 17.1-29.5) and 25.6% (95% CI: 17.6-35.8), respectively. The pooled effect leading to a change of management was 59.6% (95% CI 39.4-77.0). CONCLUSIONS: Aβ-PET has a highly significant impact on both changes in diagnosis and management among patients being seen at a specialty memory clinic.
Authors: Susan M Landau; Christopher Breault; Abhinay D Joshi; Michael Pontecorvo; Chester A Mathis; William J Jagust; Mark A Mintun Journal: J Nucl Med Date: 2012-11-19 Impact factor: 10.057
Authors: Rik Ossenkoppele; Niels D Prins; Yolande A L Pijnenburg; Afina W Lemstra; Wiesje M van der Flier; Sofie F Adriaanse; Albert D Windhorst; Ron L H Handels; Claire A G Wolfs; Pauline Aalten; Frans R J Verhey; Marcel M Verbeek; Mark A van Buchem; Otto S Hoekstra; Adriaan A Lammertsma; Philip Scheltens; Bart N M van Berckel Journal: Alzheimers Dement Date: 2012-11-16 Impact factor: 21.566
Authors: Rik Vandenberghe; Koen Van Laere; Adrian Ivanoiu; Eric Salmon; Christine Bastin; Eric Triau; Steen Hasselbalch; Ian Law; Allan Andersen; Alex Korner; Lennart Minthon; Gaëtan Garraux; Natalie Nelissen; Guy Bormans; Chris Buckley; Rikard Owenius; Lennart Thurfjell; Gill Farrar; David J Brooks Journal: Ann Neurol Date: 2010-09 Impact factor: 10.422
Authors: Victor L Villemagne; Rachel S Mulligan; Svetlana Pejoska; Kevin Ong; Gareth Jones; Graeme O'Keefe; J Gordon Chan; Kenneth Young; Henri Tochon-Danguy; Colin L Masters; Christopher C Rowe Journal: Eur J Nucl Med Mol Imaging Date: 2012-03-08 Impact factor: 9.236
Authors: S Schönecker; C Prix; T Raiser; N Ackl; E Wlasich; G Stenglein-Krapf; E Mille; M Brendel; O Sabri; M Patt; H Barthel; P Bartenstein; J Levin; A Rominger; A Danek Journal: Nervenarzt Date: 2017-02 Impact factor: 1.214
Authors: Christopher James Carswell; Zarni Win; Kirsty Muckle; Angus Kennedy; Adam Waldman; Gemma Dawe; Tara D Barwick; Sameer Khan; Paresh A Malhotra; Richard J Perry Journal: J Neurol Neurosurg Psychiatry Date: 2017-10-10 Impact factor: 10.154
Authors: Milos D Ikonomovic; William E Klunk; Eric E Abrahamson; Chester A Mathis; Julie C Price; Nicholas D Tsopelas; Brian J Lopresti; Scott Ziolko; Wenzhu Bi; William R Paljug; Manik L Debnath; Caroline E Hope; Barbara A Isanski; Ronald L Hamilton; Steven T DeKosky Journal: Brain Date: 2008-03-12 Impact factor: 13.501
Authors: Yat-Fung Shea; Warren Barker; Maria T Greig-Gusto; David A Loewenstein; Steven T DeKosky; Ranjan Duara Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Eino Solje; Alberto Benussi; Emanuele Buratti; Anne M Remes; Annakaisa Haapasalo; Barbara Borroni Journal: Diagnostics (Basel) Date: 2021-04-27
Authors: Yi-Wen Bao; Anson C M Chau; Patrick Ka-Chun Chiu; Yat Fung Shea; Joseph S K Kwan; Felix Hon Wai Chan; Henry Ka-Fung Mak Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Yi-Wen Bao; Yat-Fung Shea; Patrick Ka-Chun Chiu; Joseph S K Kwan; Felix Hon-Wai Chan; Henry Ka-Fung Mak Journal: Sci Rep Date: 2022-06-20 Impact factor: 4.996